Navigation Links
Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
Date:3/6/2013

lene Pharmaceuticals
Cylene Pharmaceuticals is a clinical-stage private company developing small molecule drugs against newly validated targets in essential cancer pathways.  The Company's Pol I program provides a non-genotoxic mechanism for activating p53 to kill cancer cells.  Cylene's leadership in exploiting CK2 pathways enables rational drug combinations for improved treatment outcomes against many cancer indications.  Cylene's unique approaches deliver innovative cancer agents that can enable pharmaceutical companies to expand their portfolios and extend the efficacy, lifecycle and reach of current cancer therapeutics. For more information on Cylene and its programs, please visit www.cylenepharma.com.

About TetraGene
TetraGene leverages a novel platform technology to develop cancer drugs that target well-validated cancer-causing oncogenes previously considered as undruggable by the pharmaceutical industry. This technology exploits a gene regulatory mechanism where the expression of a gene is controlled by folded DNA structures (called G-quadruplex DNA). By targeting gene transcription, TetraGene has carved out a niche where its technology platform can be directly applied to inhibit these undruggable cancer targets.  For more information about TetraGene please visit www.tetragene.com.


'/>"/>
SOURCE Cylene Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
2. Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders
3. Tarix Pharmaceuticals Peptide Technology Stimulates Revascularization Following Ischemia
4. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
5. TauRx Pharmaceuticals Receives $10.5m Follow-On Investment from Dundee Corporation
6. Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders
7. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
8. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
9. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
10. AVANIR Pharmaceuticals To paticipate in two conferences in March
11. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery ... report financial results for the first quarter fiscal year ... scheduled a conference call that same day, Thursday, November ... results. Interested parties can access the ...
(Date:10/30/2014)... WARSAW, Ind. , Oct. 30, 2014  Zimmer ... ZMH) today announced the future executive leadership team and ... of the Biomet transaction.  Zimmer also announced that the ... brands and will be named Zimmer Biomet, with the ... company following the closing of the merger.  The future ...
(Date:10/30/2014)... NEW YORK , Oct. 30, 2014  The ... United States is growing steadily, thanks to ... years, as a result of the economic downturn, retail ... was a year of opportunities, as the number of ... market researcher,s report, Retail Clinics Market Overview and ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9Report: Drugstore Chains Drive Retail Clinic Growth 2Report: Drugstore Chains Drive Retail Clinic Growth 3
... Calif., April 29, 2011 First Quarter ... by 321 institutions, up from 239 in Q4 2010 ... revenue Operational focus enables lower planned expense growth in ... by Astellas NGX-1998 Phase 2 clinical trial continues in ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... cancers and infectious diseases, announced today that the company will ... Securities Research Conference San Francisco, CA, May 9-11, 2011 ... Dr. J. Joseph Kim, Ph.D., President & CEO May ...
Cached Medicine Technology:NeurogesX Reports First Quarter 2011 Results 2NeurogesX Reports First Quarter 2011 Results 3NeurogesX Reports First Quarter 2011 Results 4NeurogesX Reports First Quarter 2011 Results 5NeurogesX Reports First Quarter 2011 Results 6NeurogesX Reports First Quarter 2011 Results 7NeurogesX Reports First Quarter 2011 Results 8Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
(Date:10/30/2014)... 30, 2014 USARAD Holdings ... teleradiology and specialty telemedicine solutions provider, including ... its existing teleradiology services at Mission Bend ER, ... expert telemedicine services, to the state-of-the-art, 24/7, freestanding ... result of this innovative partnership, there will be ...
(Date:10/30/2014)... 2014 The human brain is often ... exercised to help maintain better mental health, according to ... Express: Lose Your Memory in 100 Ways’ for just ... sometimes conflicting attitudes to help keep the reader constantly ... reader must decipher the hidden logic within. , “If ...
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, ... during pregnancy may have effects on genital development in baby ... boys born to moms with greater exposure to a chemical ... the space between the genitals and anus. Anogenital distance is ... exposure to androgens ("male" hormones) during pregnancy. The researchers ...
Breaking Medicine News(10 mins):Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3
... Maharashtra have crashed the efforts of the state to become ... a polio-eradication drive have detected a 9-year old girl with ... affected by the P1 strain of the virus that is ... Chief Minister, Mr Vilasrao Deshmukh, and the Health Minister, Dr ...
... weight seems to have a connection, suggests a new ... to // indicate that babies who weigh less than ... down with Irritable Bowel Syndrome , in comparison to ... documented in the Journal "Gut". ,IBS is annoying, ...
... new study in the October issue of Radiology says ... osteoporotic fractures in women with 75 percent accuracy.// Researchers ... plan accordingly., ,"Approximately 45 percent of women have ... and their spine, leading to uncertainty as to how ...
... cells that may also explain how it evades the immune ... of Illinois at Chicago College of Medicine. ,The ... of Cell Biology. ,Both strains of the herpes ... the mouth, and HSV-2, genital herpes -- can infect the ...
... share vital information with the sincere motive of protecting ... The time is ripe to evolve a cohesive international ... necessitate the sharing of important information regarding influenza virus ... bird flu has taken flight and spread around the ...
... to the scientists from the University of Newcastle, UK, ... disease can eliminate the damage caused in cirrhosis of ... that fibrosis; the scarring linked with cirrhosis is irreversible, ... can be reversed by using Sulphasalazine.,Heavy drinking and obesity ...
Cached Medicine News:Health News:Formula Predicts Osteoporotic Fracture Risk 2Health News:Herpes Infects Cornea, Evades Immune Cells 2
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
Inquire...
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
... is comprised of the TEG analyzer and the ... picture of the formation and dissolution of the ... two systems. ,Haemoscope's TEG analyzer is the only ... the reliable and proven model developed by Prof. ...
Medicine Products: